Timeline
Trellus Health suspends AIM trading as funding options run short
Trellus renews Pfizer licence for IBD app content
Trellus Health signs MSA with Gastro Health to deploy TrialSet
More in Healthcare Services
Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew
A clinical setback dominated the health and biotech session, as AstraZeneca shed more than 7% after its Phase III CARDIO-TTRansform trial of Wainua in heart disease failed to meet its primary endpoint, the most significant event in an otherwise deal- and financing-focused day for the sector.